Malformation risks higher among infants exposed in utero to TMP-SMX vs beta-lactams
First-trimester exposure to trimethoprim-sulfamethoxazole (TMP-SMX) poses a much higher risk of severe cardiac malformation and cleft lip and palate, among others, when compared with exposure to beta-lactam antibiotics during the same period, according to a study.
